Crowley Anna Lisa, Yow Eric, Barnhart Huiman X, Daubert Melissa A, Bigelow Robert, Sullivan Daniel C, Pencina Michael, Douglas Pamela S
Department of Medicine, Duke University, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina.
Duke Clinical Research Institute, Durham, North Carolina.
J Am Soc Echocardiogr. 2016 Dec;29(12):1144-1154.e7. doi: 10.1016/j.echo.2016.08.006. Epub 2016 Oct 6.
There is no broadly accepted standard method for assessing the quality of echocardiographic measurements in clinical research reports, despite the recognized importance of this information in assessing the quality of study results.
Twenty unique clinical studies were identified reporting echocardiographic data quality for determinations of left ventricular (LV) volumes (n = 13), ejection fraction (n = 12), mass (n = 9), outflow tract diameter (n = 3), and mitral Doppler peak early velocity (n = 4). To better understand the range of possible estimates of data quality and to compare their utility, reported reproducibility measures were tabulated, and de novo estimates were then calculated for missing measures, including intraclass correlation coefficient (ICC), 95% limits of agreement, coefficient of variation (CV), coverage probability, and total deviation index, for each variable for each study.
The studies varied in approaches to reproducibility testing, sample size, and metrics assessed and values reported. Reported metrics included mean difference and its SD (n = 7 studies), ICC (n = 5), CV (n = 4), and Bland-Altman limits of agreement (n = 4). Once de novo estimates of all missing indices were determined, reasonable reproducibility targets for each were identified as those achieved by the majority of studies. These included, for LV end-diastolic volume, ICC > 0.95, CV < 7%, and coverage probability > 0.93 within 30 mL; for LV ejection fraction, ICC > 0.85, CV < 8%, and coverage probability > 0.85 within 10%; and for LV mass, ICC > 0.85, CV < 10%, and coverage probability > 0.60 within 20 g.
Assessment of data quality in echocardiographic clinical research is infrequent, and methods vary substantially. A first step to standardizing echocardiographic quality reporting is to standardize assessments and reporting metrics. Potential benefits include clearer communication of data quality and the identification of achievable targets to benchmark quality improvement initiatives.
尽管在评估研究结果质量时,超声心动图测量信息的重要性已得到认可,但在临床研究报告中,尚无广泛接受的评估超声心动图测量质量的标准方法。
确定了20项独特的临床研究,这些研究报告了用于测定左心室(LV)容积(n = 13)、射血分数(n = 12)、质量(n = 9)、流出道直径(n = 3)和二尖瓣多普勒早期峰值流速(n = 4)的超声心动图数据质量。为了更好地了解数据质量可能估计值的范围并比较其效用,将报告的重复性测量值制成表格,然后针对每个研究的每个变量,计算缺失测量值的重新估计值,包括组内相关系数(ICC)、95%一致性界限、变异系数(CV)、覆盖概率和总偏差指数。
这些研究在重复性测试方法、样本量、评估指标和报告值方面存在差异。报告的指标包括平均差值及其标准差(n = 7项研究)、ICC(n = 5)、CV(n = 4)和Bland-Altman一致性界限(n = 4)。一旦确定了所有缺失指标的重新估计值,就将大多数研究达到的目标确定为每个指标的合理重复性目标。这些目标包括,对于左心室舒张末期容积,ICC > 0.95,CV < 7%,在30 mL范围内覆盖概率 > 0.93;对于左心室射血分数,ICC > 0.85,CV < 8%,在10%范围内覆盖概率 > 0.85;对于左心室质量,ICC > 0.85,CV < 10%,在20 g范围内覆盖概率 > 0.60。
超声心动图临床研究中的数据质量评估并不常见,且方法差异很大。标准化超声心动图质量报告的第一步是标准化评估和报告指标。潜在益处包括更清晰地传达数据质量以及确定可实现的目标,以衡量质量改进举措。